查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541158

2024-2032 年脫髮治療市場報告（按藥物類型、適應症、性別、給藥途徑、配銷通路和地區）

Alopecia Treatment Market Report by Drug Type, Indication, Gender, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球脫髮治療市場規模達33億美元。該市場的推動因素包括脫髮日益流行、醫療保健支出的大量投資以及消費者日益成長的美學意識，凸顯了外表和自我照顧的重要性。

脫髮治療市場分析：

主要市場促進因素：由於醫療保健成本的上升和脫髮（包括斑禿和遺傳性脫髮）患病率的上升，對有效治療替代方案的需求不斷成長。

主要市場趨勢：脫髮治療市場的成長是由不斷成長的美學意識推動的，受到社交媒體和理想美容標準的影響，而對脫髮狀況的認知不斷提高，鼓勵人們尋求脫髮治療的醫療援助。

地理趨勢：脫髮治療市場預測顯示將大幅成長，尤其是在美國等國家，醫療保健支出的成長推動了市場擴張。由於美容問題的增加，城市社區和年輕人對脫髮治療的需求不斷增加。

競爭格局：一些主要的脫髮治療公司包括 Aclaris Therapeutics Inc.、Cellmid Limited、Cipla Limited、Dr. Reddy's Laboratories Ltd.、GlaxoSmithKline plc、HCell Inc.、Johnson & Johnson、Merck & Co. Inc.、Pfizer Inc.。 、大正製藥控股有限公司、梯瓦製藥工業股份有限公司等。

挑戰與機會：挑戰包括與特定治療相關的高昂費用、有限的保險範圍以及對特定干涉措施可能產生的不良反應。脫髮治療市場近期的機會包括提供高效、微創治療的技術發展，以及透過集中行銷和宣傳工作擴大市場範圍。

脫髮治療市場趨勢：

脫髮盛行率增加

雄性禿是男性和女性中常見的一種常見的脫髮形式。根據美國皮膚病學會雜誌(JAAD) 2023 年發表的調查顯示，脫髮對不同種族和性別群體的影響不同，15% 的停經後女性和超過50% 的老年男性都會經歷脫髮，而頭髮稀疏最早就開始出現作為青春期。除此之外，推動脫髮治療市場向前發展的主要因素之一是脫髮患病率不斷上升，其中包括遺傳性脫髮和斑禿等疾病。國家斑禿基金會估計，有 670 萬美國人和全世界約 1.6 億人患有斑禿或可能患有斑禿。目前，美國約有 70 萬人患有斑禿。此外，全世界約有 2% 的人患有斑禿，這凸顯了這種導致脫髮的疾病的廣泛流行。根據脫髮治療市場概況，隨著越來越多的人意識到並尋求有效的治療解決方案，該行業的需求正在上升。因此，由於醫療技術的進步和廣泛的治療選擇，人們開始求助於頭髮修復的醫療援助，導致脫髮治療市場大幅擴張。

醫療保健支出增加

全球醫療保健支出不斷增加是推動脫髮治療市場成長的關鍵因素。 2020 年，全球醫療保健支出平均成長21%。增加。在有資料的國家中，比利時的人均醫療支出增幅最大，2021年至2022年間成長了9.6%。脫髮治療。因此，財務能力的增強和可支配收入的增加，使更多的人能夠負擔得起脫髮治療，從而促進了市場的成長。

審美意識不斷增強

此外，全球個人對外表和美學意識的日益重視，大大促進了脫髮治療市場的擴張。國際毛髮修復外科協會 (ISHRS) 進行的一項調查顯示，ISHRS 成員平均治療了 165 名手術患者和 396 名非手術患者。此外，2021 年，大約三分之二(65%) 的ISHRS 會員進行了0-199 次毛髮修復手術，平均每位會員進行了179 次手術，而78% 的ISHRS 會員進行了0-19 次毛髮修復手術。 2021 年，會員平均每月完成 14 例頭髮修復手術。堅持感知的美學理想和文化壓力的需要導致了對有效頭髮修復選擇的顯著需求。因此，隨著越來越多的人尋找改善外觀和解決脫髮問題的方法，脫髮治療市場正在不斷成長。

脫髮治療市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據藥物類型、適應症、性別、給藥途徑和配銷通路對市場進行了分類。

按藥物類型細分：

米諾地爾

非那雄胺

其他

米諾地爾佔據大部分市場佔有率

該報告根據藥物類型對市場進行了詳細的細分和分析。這包括米諾地爾、非那雄胺等。根據該報告，米諾地爾代表了最大的部分。

米諾地爾是一種常用藥物，可有效治療多種形式的脫髮。米諾地爾是治療男性和女性型禿頭的一種流行且易於使用的治療選擇。在許多地方都可以透過櫃檯購買。這種 FDA 核准的藥物有多種形式，包括泡沫劑和局部治療劑。它可以減緩脫髮，刺激頭髮生長，並增加毛囊的血液供應。由於與處方藥相比其價格相對便宜且具有促進頭髮生長的功效，因此被廣泛採用。例如，根據Research Gate 的一項研究，患者接受低劑量口服米諾地爾(LDOM) 治療至少3 個月，作為治療任何類型脫髮的方法，這為治療脫髮提供了良好的安全性，但沒有任何生命- 威脅性的不良反應。因此，脫髮人數的增加導致採用米諾地爾來治療脫髮，從而積極產生脫髮治療市場收入。

按指示細分：

雄性禿

斑禿

全禿

其他

雄性禿佔業界最大佔有率

報告還提供了基於指示的詳細市場細分和分析。這包括雄性禿、斑禿、全禿等。報告稱，雄​​性禿佔據了最大的市場。

雄性禿，通常稱為男性或女性型禿髮，佔據了市場上最大的部分。這主要是由於雄性禿在全球盛行，影響了很大一部分男性和女性。此外，人們對治療方案的認知和接受度不斷提高，加上局部治療、口服藥物和植髮手術等治療技術的進步，進一步推動了市場的成長。因此，主要參與者正在推出先進的產品變體來滿足這些需求。例如，2024年2月，臨床階段的再生醫學公司Pelage Pharmaceuticals創造了一種治療脫髮的新型療法，同時宣布完成1,675萬美元的A輪融資。這筆資金將有助於開發針對雄性禿（型禿髮）和其他類型脫髮（包括化療引起的脫髮）的一流治療方法。 GV 領投，並獲得 Main Street Advisors、Visionary Ventures 和 YK BioVentures 的支持。因此，人們越來越關注脫髮的美觀和心理影響，導致對有效治療解決方案的需求不斷成長，從而鞏固了雄激素性脫髮在脫髮治療市場前景中的地位。

按性別分類：

男性

女性

女性代表主導細分市場

該報告根據性別對市場進行了詳細的細分和分析。這包括男性和女性。根據該報告，女性佔最大部分。

女性脫髮的盛行率不斷上升，加上人們對脫髮藥物治療的認知和接受度不斷提高，正在影響市場的成長。由於美學問題和脫髮的心理影響，女性正在尋求有效的脫髮解決方案，從而導致對藥物和美容治療的巨大需求。此外，專為女性脫髮設計的產品範圍不斷擴大，包括局部解決方案、口服藥物以及富血小板血漿（PRP）和低強度雷射療法（LLLT）等先進療法，進一步推動了該細分市場的成長。根據美國皮膚病學會(AAD) 協會的規定，米諾地爾被認為是經美國食品藥物管理局(FDA) 批准用於治療女性型禿頭(FPHL) 的非處方藥物，因為FPHL 可以透過以下方法治療：含有 2% 或 5% 米諾地爾的藥物。因此，對以女性為中心的行銷策略的日益關注以及女性自我照顧和健康的上升趨勢也有助於脫髮治療市場的擴大。

依給藥途徑分類：

口服

專題

可注射

主題在市場上表現出明顯的主導地位

報告還提供了基於給藥途徑的詳細市場細分和分析。這包括口服、局部和注射。報告顯示，外用佔據了最大的市場佔有率。

主題細分市場佔有最大佔有率，因為其易於使用而被廣泛使用和接受。包括米諾地爾和皮質類固醇在內的局部療法是非侵入性的，可以直接施用到受影響的區域，並且比口服和注射療法具有更少的全身性不良反應，並且通常是防止脫髮的第一道防線。這種給藥途徑因其在不需要醫生護理的情況下想要快速修復的患者的歡迎而受到歡迎。據克利夫蘭診所稱，皮質類固醇和其他抗發炎藥物可用於治療脫髮。它以軟膏、霜劑或泡沫的形式局部塗抹（皮膚），或注射到頭皮或其他區域進行治療。

按配銷通路分類：

醫院

零售藥局

網路藥局

醫院主導市場

該報告根據配銷通路對市場進行了詳細的細分和分析。這包括醫院、零售藥局和網路藥局。報告稱，醫院佔最大部分。

醫院的主導地位歸因於醫院環境中廣泛的基礎設施和專業的醫療專業知識，這確保了脫髮患者的全面診斷和量身定做的治療計劃。醫院通常提供一系列治療選擇，包括處方藥、先進的醫療程序和支持性護理，使它們成為尋求專業和有效的脫髮治療的個人的首選。因此，與醫院護理相關的信任和可靠性有助於其在脫髮治療市場中的領先地位。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美引領市場，佔據最大的脫髮治療市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是脫髮治療最大的區域市場。

北美脫髮治療市場最近的發展特點是醫療基礎設施健全、脫髮患病率不斷上升以及對可用治療方案的認知不斷提高。主要製藥公司的存在和醫療技術的進步進一步支撐了該地區的市場。例如，2023年6月，美國食品藥物管理局（FDA）宣布批准耶魯大學皮膚科醫生Brett King博士開發的Janus激酶（JAK）抑制劑ritlecitinib，他與輝瑞製藥公司合作進行了一系列臨床試驗與利特西替尼。它是一種口服藥物，用於治療青少年和成人的斑禿，名為 Litfulo。此外，對美容手術的日益成長和更高的可支配收入使消費者能夠花在脫髮治療上，這積極增加了北美的脫髮治療需求。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。脫髮治療行業的一些主要市場參與者包括 Aclaris Therapeutics Inc.、Cellmid Limited、Cipla Limited、Dr. Reddy's Laboratories Ltd.、葛蘭素史克公司、HCell Inc.、強生公司、默克公司、輝瑞公司.、大正製藥控股有限公司、梯瓦製藥工業股份有限公司等

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

全球市場的主要參與者正在積極參與多項策略性舉措，以保持競爭優勢。他們大力投資研發，以引入創新的治療方法和療法，以提高療效並減少副作用。此外，這些參與者正致力於透過進入新興市場並利用對脫髮解決方案不斷成長的需求來擴大其全球影響力。與皮膚科診所和醫療保健提供者的合作和夥伴關係變得越來越普遍，以確保更廣泛的分銷網路。此外，一些公司正在利用數位行銷和電子商務平台來推廣其產品並覆蓋更廣泛的消費者群體，強調便利性和可及性。例如，2023 年3 月6 日，Sun Pharmaceutical Industries Limited 及其子公司和/或聯營公司（稱為Sun Pharma）宣布成功完成對Concert Pharmaceuticals, Inc. 的收購。正在開發deuruxolitinib 是一種新型氘化口服 JAK1/2 抑制劑，可用於治療中度至重度斑禿成人患者。

脫髮治療市場新聞：

2023 年 12 月 5 日：Aclaris Therapeutics, Inc. 是一家致力於開發免疫發炎性疾病創新療法的臨床階段生物製藥公司，宣布與 Sun Pharmaceutical Industries, Inc.（現為 Sun Pharma）簽署獨家專利授權協議。 Aclaris 已授予 Sun Pharma 使用 deuruxolitinib、Sun Pharma 的 JAK 抑制劑或其他同位素形式的 ruxolitinib 治療斑禿 (AA) 和雄激素性脫髮 (AGA) 的某些專利的獨家權利。其中包括 1500 萬美元的預付款、監管和商業里程碑以及特許權使用費。 Aclaris 僅從第三方獲得專利許可，由於單獨的合約承諾，有義務分享從 Sun Pharma 收到的部分對價。

2024 年 5 月 14 日：REVIAN Inc. 是一家專門利用精確波長的 LED 光進行頭髮和皮膚再生的醫療技術公司，宣布參加定於達拉斯舉行的 2024 年皮膚病研究學會年會。活動期間，Jacob Kocher 博士展示了一張資料，其中詳細介紹了Revian 的專利波長組合可將雙氫睪酮(DHT) 產量減少74%，顯著優於行業標準非那雄胺，後者在使用後24 小時內將DHT 減少了38%。眾所周知，雙氫睪酮在雄性禿或禿髮的發展中起著至關重要的作用。

本報告回答的關鍵問題

  • 2023年全球脫髮治療市場規模是多少
  • 2024-2032年全球脫髮治療市場的預期成長率是多少
  • 推動全球脫髮治療市場的關鍵因素是什麼
  • COVID-19 對全球脫髮治療市場有何影響
  • 根據藥物類型，全球脫髮治療市場的詳細情形如何
  • 根據適應症，全球脫髮治療市場的細分是什麼
  • 全球脫髮治療市場按性別分類的情況如何
  • 根據給藥途徑，全球脫髮治療市場的詳細情形如何
  • 基於配銷通路的全球脫髮治療市場的細分是什麼
  • 10. 全球脫髮治療市場的重點區域有哪些？
  • 11. 全球脫髮治療市場的主要參與者/公司有哪些？

本報告回答的關鍵問題

  • 2023年全球脫髮治療市場規模有多大？ 2024-2032年全球脫髮治療市場的預期成長率是多少？
  • 推動全球脫髮治療市場的關鍵因素是什麼？
  • COVID-19 對全球脫髮治療市場有何影響？
  • 根據藥物類型，全球脫髮治療市場的詳細情形如何？
  • 根據適應症，全球脫髮治療市場的詳細情形如何？
  • 全球脫髮治療市場按性別分類的情況如何？
  • 根據給藥途徑，全球脫髮治療市場的詳細情形如何？
  • 基於配銷通路的全球脫髮治療市場的細分是什麼？
  • 全球脫髮治療市場的關鍵地區有哪些？
  • 全球脫髮治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球脫髮治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依藥物類型

  • 米諾地爾
    • 市場趨勢
    • 市場預測
  • 非那雄胺
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依跡象

  • 雄性禿
    • 市場趨勢
    • 市場預測
  • 斑禿
    • 市場趨勢
    • 市場預測
  • 全禿
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依性別

  • 男性
    • 市場趨勢
    • 市場預測
  • 女性
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：依管理途徑

  • 口服
    • 市場趨勢
    • 市場預測
  • 專題
    • 市場趨勢
    • 市場預測
  • 可注射
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按配銷通路

  • 醫院
    • 市場趨勢
    • 市場預測
  • 零售藥局
    • 市場趨勢
    • 市場預測
  • 網路藥局
    • 市場趨勢
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Aclaris Therapeutics Inc.
    • Cellmid Limited
    • Cipla Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • HCell Inc.
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Pfizer Inc.
    • Taisho Pharmaceutical Holdings Co. Ltd
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A4147

The global alopecia treatment market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The market is driven by the increasing prevalence of alopecia, significant investment in healthcare expenditure, and the growing aesthetic consciousness among consumers highlighting the importance of appearance and self-care.

Alopecia Treatment Market Analysis:

Major Market Drivers: The growing need for efficient treatment alternatives is due to the rise in healthcare costs and the rising prevalence of alopecia, including alopecia areata and hereditary hair loss.

Key Market Trends: The alopecia treatment market growth is driven by the growing aesthetic consciousness, influenced by social media and ideal beauty standards, and increasing awareness about alopecia conditions is encouraging people to seek medical assistance for hair loss treatment.

Geographical Trends: The alopecia treatment market forecasts indicate a substantial increase, especially in nations like the US, where growing healthcare spending fuels market expansion. Urban communities and younger people are increasing the demand for alopecia treatments owing to increased cosmetic concerns.

Competitive Landscape: Some of the major alopecia treatment companies include Aclaris Therapeutics Inc., Cellmid Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Taisho Pharmaceutical Holdings Co. Ltd, Teva Pharmaceutical Industries Ltd., among many others.

Challenges and Opportunities: The challenges consist of the exorbitant expenses linked to specific treatments, restricted insurance coverage, and possible adverse reactions to specific interventions. The alopecia treatment market recent opportunities include technical developments that offer efficient and minimally invasive treatments and the expansion of market reach through focused marketing and awareness efforts.

Alopecia Treatment Market Trends:

Increasing Prevalence of Alopecia

Androgenetic alopecia is a prevalent form of patterned hair loss that is seen in men and women. As per the Journal of the American Academy of Dermatology International (JAAD) published survey in 2023, alopecia affects different racial and gender groups differently, 15% of postmenopausal women and over 50% of elderly males experience it, while thinning hair can begin as early as puberty. Besides this, one of the main factors driving the alopecia treatment market forward is the rising prevalence of alopecia, which includes inherited hair loss and disorders like alopecia areata. The National Alopecia Areata Foundation estimates that 6.7 million Americans and about 160 million individuals worldwide have alopecia areata or may acquire it. Currently, alopecia areata affects about 700,000 persons in the United States. Furthermore, alopecia areata affects about 2% of people worldwide, underscoring the disorder's widespread prevalence that causes hair loss. As per the alopecia treatment market overview, demand in the industry is rising as more individuals become aware and look for efficient treatment solutions. Therefore, people are resorting to medical aid for hair restoration due to advances in medical technology and a wide range of treatment options accessible, leading to a considerable expansion in the market for alopecia therapy.

Rising Healthcare Expenditure

The escalating healthcare expenditure worldwide is a pivotal factor driving the growth trajectory of the alopecia treatment market. Global healthcare spending increased by 21% on average in 2020. This number has increased even further by 2021, when it was a startling 25% higher than in 2019. Moreover, the per capita health spending increased in most peer countries between 2021 and 2022. A moderate 2.9% growth in per capita health spending was reported in the US, Australia (2.4%), Canada (0.7%), and the UK (0.5%). Among the countries for whom data was available, Belgium experienced the largest growth in per capita health spending, rising 9.6% between 2021 and 2022. Notably, developed nations show an especially notable increase in healthcare spending, indicating the willingness of individuals to spend money on cutting-edge medical treatments, such as alopecia treatments. Hence, the growing financial capacity and increased disposable income, allow more people to afford alopecia treatments, thus contributing to the market growth.

Growing Aesthetic Consciousness

Furthermore, the growing emphasis on physical appearance and aesthetic consciousness among individuals globally is significantly contributing to the expansion of the alopecia treatment market. A survey conducted by the International Society of Hair Restoration Surgery (ISHRS) revealed that ISHRS members treated on average 165 surgical patients and 396 non-surgical patients. Moreover, ISHRS members performed surgical procedures between 0-199 hair restoration in 2021 by around two-thirds (65%) of ISHRS members, with an average member performing 179 procedures, while 78% of ISHRS members performed 0-19 hair restoration surgical operations. Members completed an average of 14 hair restoration surgical procedures per month in 2021. As a result, this rising figure illustrates increased self-consciousness among individuals about their appearance, which is exacerbated by social media's effect and the representation of ideal beauty standards. The need to adhere to perceived aesthetic ideals and cultural pressures has resulted in a noteworthy demand for effective hair restoration options. Consequently, the market for alopecia treatments is growing as more people look for ways to improve their physical appearance and deal with their hair loss issues.

Alopecia Treatment Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on drug type, indication, gender, route of administration, and distribution channel.

Breakup by Drug Type:

Minoxidil

Finasteride

Others

Minoxidil accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the drug type. This includes minoxidil, finasteride, and others. According to the report, minoxidil represented the largest segment.

Minoxidil is a commonly used medication that effectively treats alopecia in many forms. Minoxidil is a popular and easily accessible therapy option for male and female pattern hair loss. It is available over the counter in many locations. This FDA-approved drug comes in several forms, including foams and topical treatments. It slows down hair loss, stimulates hair growth, and increases blood supply to hair follicles. It is widely adopted due to its relative affordability when compared to prescription drugs and its efficacy in encouraging hair growth. For instance, as per a study by Research Gate, patients were treated with low-dose oral minoxidil (LDOM) for at least 3 months as a treatment for any type of alopecia, which offers a good safety profile to treat hair loss without any life-threatening adverse effects. Thus, the increasing number of alopecia is resulting in the adoption of minoxidil to treat alopecia, positively generating alopecia treatment market revenue.

Breakup by Indication:

Androgenic Alopecia

Alopecia Areata

Alopecia Totalis

Others

Androgenic alopecia holds the largest share of the industry

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes androgenic alopecia, alopecia areata, alopecia totalis, and others. According to the report, androgenic alopecia accounted for the largest market share.

Androgenic alopecia, commonly known as male or female pattern baldness, holds the largest segment in the market. It is primarily due to the high prevalence of androgenic alopecia globally, which affects a significant portion of men and women. Additionally, the rising awareness and acceptance of treatment options, coupled with advances in therapeutic techniques such as topical treatments, oral medications, and hair transplant procedures, have further propelled the market growth. Hence key players are introducing advanced product variants to meet these needs. For instance, in February 2024, Pelage Pharmaceuticals, a clinical-stage regenerative medicine company created a novel treatment for hair loss, while announcing the completion of $16.75 million Series A fundraising. The funding will assist the development of a first-in-class treatment for androgenetic alopecia (pattern baldness) and other kinds of alopecia, including chemotherapy-induced hair loss. GV is leading the investment, which is also supported by Main Street Advisors, Visionary Ventures, and YK BioVentures. As a result, the increasing focus on aesthetic appearance and the psychological impact of hair loss has led to the rising demand for effective treatment solutions, solidifying androgenic alopecia's position in the alopecia treatment market outlook.

Breakup by Gender:

Male

Female

Female represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on gender. This includes male and female. According to the report, females represented the largest segment.

The growing prevalence of alopecia in females coupled with a growing awareness and acceptance of medical treatments for hair loss are influencing the market growth. Women are seeking effective solutions for alopecia due to aesthetic concerns and the psychological impact of hair loss, leading to a significant demand for pharmaceutical and cosmetic treatments. Additionally, the expansion of product offerings specifically designed for female alopecia, including topical solutions, oral medications, and advanced therapies such as platelet-rich plasma (PRP) and low-level laser therapy (LLLT), has further propelled the growth of this segment. As per the American Academy of Dermatology (AAD) association, minoxidil is recognized as an over-the-counter medication approved by the US Food and Drug Administration (FDA) for treating female pattern hair loss (FPHL), since FPHL can be treated with medications that include 2% or 5% minoxidil. Therefore, the growing focus on female-centric marketing strategies and the rising trend of self-care and wellness among women are also contributing to the expansion of alopecia treatment market.

Breakup by Route of Administration:

Oral

Topical

Injectable

Topical exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral, topical, and injectable. According to the report, topical accounted for the largest market share.

Topical segment holds the largest share, as it is widely used and accepted owing to its ease of use. Topical therapies, including minoxidil and corticosteroids, are non-invasive, can be administered directly to the afflicted area, and have fewer systemic adverse effects than oral and injectable options, and are frequently the first line of defense against hair loss. This route of administration is attributed to its popularity among patients who want quick fixes that work well without requiring physician care. According to the Cleveland Clinic, corticosteroids and other anti-inflammatory medications can be used to treat alopecia. It is rubbed topically (into the skin) as an ointment, cream, or foam, or injected into the scalp or other regions for the treatment.

Breakup by Distribution Channel:

Hospitals

Retail Pharmacies

Online Pharmacies

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospitals, retail pharmacies, and online pharmacies. According to the report, hospitals represented the largest segment.

Hospital dominance is attributed to the extensive infrastructure and specialized medical expertise available in hospital settings, which ensure comprehensive diagnosis and tailored treatment plans for alopecia patients. Hospitals often provide a range of therapeutic options, including prescription medications, advanced medical procedures, and supportive care, making them a preferred choice for individuals seeking professional and effective alopecia management. Hence, the trust and reliability associated with hospital care contribute to their leading position in the alopecia treatment market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest alopecia treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for alopecia treatment.

The North America alopecia treatment market recent developments are marked by the robust healthcare infrastructure, increasing prevalence of alopecia, and increased awareness about available treatment options. The presence of major pharmaceutical companies and advancements in medical technology further bolster the market in this region. For instance, in June 2023, the U.S. Food and Drug Administration (FDA) announced the approval of ritlecitinib, a Janus kinase (JAK) inhibitor by Yale dermatologist Dr. Brett King, who worked with pharmaceutical company Pfizer for conducting a series of clinical trials with ritlecitinib. It is for the treatment of alopecia areata in adolescents and adults which is an oral medication under the name Litfulo. Furthermore, the growing inclination toward aesthetic procedures and a higher disposable income enable consumers to spend on treatments for hair loss, which is positively increasing the alopecia treatment demand in North America.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the alopecia treatment industry include Aclaris Therapeutics Inc., Cellmid Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Taisho Pharmaceutical Holdings Co. Ltd, Teva Pharmaceutical Industries Ltd., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The key players in the global market are actively engaged in several strategic initiatives to maintain their competitive edge. They are heavily investing in research and development to introduce innovative treatments and therapies that offer enhanced efficacy and fewer side effects. Additionally, these players are focusing on expanding their global presence by entering emerging markets and capitalizing on the growing demand for hair loss solutions. Collaborations and partnerships with dermatological clinics and healthcare providers are becoming increasingly common to ensure a wider distribution network. Moreover, several companies are leveraging digital marketing and e-commerce platforms to promote their products and reach a broader consumer base, emphasizing convenience and accessibility. For instance, on 6 March 2023, Sun Pharmaceutical Industries Limited along with its subsidiaries and/or associated companies, known as Sun Pharma announced the successful completion of its acquisition of Concert Pharmaceuticals, Inc. Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company developing deuruxolitinib, a novel deuterated oral JAK1/2 inhibitor, for the potential treatment of adult patients with moderate to severe alopecia areata.

Alopecia Treatment Market News:

5 December 2023: Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for immuno-inflammatory diseases, announced an exclusive patent license agreement with Sun Pharmaceutical Industries, Inc., now Sun Pharma. Aclaris has granted Sun Pharma exclusive rights to certain patents for the use of deuruxolitinib, Sun Pharma's JAK inhibitor, or other isotopic forms of ruxolitinib, for the treatment of alopecia areata (AA) and androgenetic alopecia (AGA). It includes an upfront payment of $15 million, and regulatory and commercial milestones, and royalties. Aclaris licenses the patents exclusively from a third party and is obligated to share a portion of the consideration received from Sun Pharma due to separate contractual commitments.

14 May 2024: REVIAN Inc., a medical technology company specializing in the use of precise wavelengths of LED light for hair and skin rejuvenation, announced its participation in the 2024 Society for Investigative Dermatology Annual Meeting, scheduled in Dallas. During the event, Dr. Jacob Kocher presented a poster detailing data that demonstrates Revian's patented combination of wavelengths reduces Dihydrotestosterone (DHT) production by 74%, significantly outperforming the industry standard finasteride, which achieved a 38% reduction in DHT at 24 hours post-treatment in the same in vitro experiment. DHT is known to play a crucial role in the development of pattern hair loss androgenic alopecia or pattern baldness.

Key Questions Answered in This Report

  • 1. What was the size of the global alopecia treatment market in 2023?
  • 2. What is the expected growth rate of the global alopecia treatment market during 2024-2032?
  • 3. What are the key factors driving the global alopecia treatment market?
  • 4. What has been the impact of COVID-19 on the global alopecia treatment market?
  • 5. What is the breakup of the global alopecia treatment market based on the drug type?
  • 6. What is the breakup of the global alopecia treatment market based on the indication?
  • 7. What is the breakup of the global alopecia treatment market based on gender?
  • 8. What is the breakup of the global alopecia treatment market based on the route of administration?
  • 9. What is the breakup of the global alopecia treatment market based on the distribution channel?
  • 10. What are the key regions in the global alopecia treatment market?
  • 11. Who are the key players/companies in the global alopecia treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Alopecia Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Minoxidil
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Finasteride
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Androgenic Alopecia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Alopecia Areata
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Alopecia Totalis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Gender

  • 8.1 Male
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Female
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Oral
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Topical
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Retail Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Online Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Aclaris Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
    • 16.3.2 Cellmid Limited
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Cipla Limited
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Dr. Reddy's Laboratories Ltd.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 GlaxoSmithKline plc
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 HCell Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Johnson & Johnson
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Merck & Co. Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Pfizer Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Taisho Pharmaceutical Holdings Co. Ltd
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Teva Pharmaceutical Industries Ltd.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Alopecia Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Alopecia Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Alopecia Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Alopecia Treatment Market: Breakup by Drug Type (in %), 2023
  • Figure 5: Global: Alopecia Treatment Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Alopecia Treatment Market: Breakup by Gender (in %), 2023
  • Figure 7: Global: Alopecia Treatment Market: Breakup by Route of Administration (in %), 2023
  • Figure 8: Global: Alopecia Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 9: Global: Alopecia Treatment Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Alopecia Treatment (Minoxidil) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Alopecia Treatment (Minoxidil) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Alopecia Treatment (Finasteride) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Alopecia Treatment (Finasteride) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Alopecia Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Alopecia Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Alopecia Treatment (Androgenic Alopecia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Alopecia Treatment (Androgenic Alopecia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Alopecia Treatment (Alopecia Areata) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Alopecia Treatment (Alopecia Areata) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Alopecia Treatment (Alopecia Totalis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Alopecia Treatment (Alopecia Totalis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Alopecia Treatment (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Alopecia Treatment (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Alopecia Treatment (Male) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Alopecia Treatment (Male) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Alopecia Treatment (Female) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Alopecia Treatment (Female) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Alopecia Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Alopecia Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Alopecia Treatment (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Alopecia Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Alopecia Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Alopecia Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Alopecia Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Alopecia Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Alopecia Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Alopecia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Alopecia Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Alopecia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Alopecia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Alopecia Treatment Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Alopecia Treatment Industry: SWOT Analysis
  • Figure 90: Global: Alopecia Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Alopecia Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Alopecia Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Alopecia Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 3: Global: Alopecia Treatment Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Alopecia Treatment Market Forecast: Breakup by Gender (in Million US$), 2024-2032
  • Table 5: Global: Alopecia Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 6: Global: Alopecia Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 7: Global: Alopecia Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Alopecia Treatment Market: Competitive Structure
  • Table 9: Global: Alopecia Treatment Market: Key Players